Gestational diabetes & diabetes in pregnancy

Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial

Diabetes CarePublished Secondary analysis of the DiGest randomised trial

Authors' conclusion

In women with GDM, CGM mean glucose <110 mg/dL (6.1 mmol/L), ≥90% TIRp, or <10% TARp using a range of 63-140 mg/dL (3.5-7.8 mmol/L) at 29 weeks' gestation was associated with a low risk of suboptimal offspring outcomes.

Study context

Population
Women with gestational diabetes mellitus (GDM) (diagnosed at median 25.1 weeks) and BMI ≥25 kg/m² receiving a dietary intervention, masked Dexcom G6 continuous glucose monitoring (CGM) at 29, 32 and 36 weeks' gestation361 with CGM at 29 weeks
Participants
425 women
Comparison
CGM metric targets achieved vs not achieved at 29 weeks
Primary endpoint
Associations of CGM metrics, including TIRp (63-140 mg/dL), with pregnancy outcomes
Methodological detailsmasked CGM, logistic regression, ROC curves and Youden index
  • Masked CGM
  • Logistic regression
  • ROC curves and Youden index

Primary result

As reported in the abstract

29 weeks
Large for gestational age (LGA), mean glucose <110 mg/dL: OR
0.41 (0.22, 0.77) (95% CI)
LGA, TIRp ≥90%: OR
0.38 (0.20, 0.70) (95% CI)
LGA, TARp <10%: OR
0.39 (0.20, 0.73) (95% CI)
Small for gestational age (SGA), mean glucose <110 mg/dL: OR
0.26 (0.08, 0.79) (95% CI)
SGA, TIRp ≥90%: OR
0.30 (0.10, 0.91) (95% CI)
SGA, TARp <10%: OR
0.19 (0.06, 0.62) (95% CI)

Further findings

Preterm birth · 29 weeks

TARp <10%: OR
0.40 (0.17, 0.94)
Mean nocturnal glucose <110 mg/dL: OR
0.42 (0.19, 0.97)

Stricter range (63-120 mg/dL)

Similar performance overall, but no single statistically robust TIR/TAR target across all outcomes

Original publication

Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial. Diabetes Care. Published 19 August 2025. doi:10.2337/dc25-0452

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.